BRAF and melanoma: Similarly, the expression levels of these genes were comparable in BRAF-, NRAS-, and NF1-mutant, as well as triple wild-type melanoma tumors (Figure S3B) indicating that the presence of mRNAs in qCLASH hybrids is not influenced by stage of disease or mutational background.